Arbutus Biopharma (ABUS) Profit After Tax Growth (3y) (2016 - 2026)
Arbutus Biopharma (ABUS) Profit After Tax Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | 9.53% |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | -27.65% |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 70.25% |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | - |
| 10 | Arbutus Biopharma | 865.18 Mn | 769.95 Mn | - | 131.37% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 131.37% |
| Dec 31, 2025 | 44.02% |
| Sep 30, 2025 | 25.17% |
| Jun 30, 2025 | 29.62% |
| Mar 31, 2025 | -15.92% |
| Dec 31, 2024 | 16.43% |
| Sep 30, 2024 | -0.91% |
| Jun 30, 2024 | -0.70% |
| Mar 31, 2024 | -2.95% |
| Dec 31, 2023 | -4.26% |
| Sep 30, 2023 | -2.29% |
| Jun 30, 2023 | -6.66% |
| Mar 31, 2023 | -5.64% |
| Dec 31, 2022 | 4.58% |
| Sep 30, 2022 | 39.28% |
| Jun 30, 2022 | 15.25% |
| Mar 31, 2022 | 12.15% |
| Dec 31, 2021 | -5.57% |
| Sep 30, 2021 | 7.79% |
| Jun 30, 2021 | -102.24% |